- Home
- FBRT vs SPRY Comparison
FBRT vs SPRY Comparison
Compare FBRT & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FBRT | SPRY |
|---|---|---|
| Founded | 2012 | 2015 |
| Country | United States | United States |
| Employees | 223 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 701.9M | 823.2M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | FBRT | SPRY |
|---|---|---|
| Price | $8.75 | $7.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $11.50 | ★ $40.00 |
| AVG Volume (30 Days) | 718.8K | ★ 1.8M |
| Earning Date | 04-29-2026 | 05-11-2026 |
| Dividend Yield | ★ 15.83% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $84,278,000.00 |
| Revenue This Year | $12.34 | $87.40 |
| Revenue Next Year | $4.95 | $81.64 |
| P/E Ratio | $13.56 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.24 | $6.66 |
| 52 Week High | $11.84 | $18.63 |
Technical Indicators
Market Signals| Indicator | FBRT | SPRY |
|---|---|---|
| Relative Strength Index (RSI) | 42.53 | 44.65 |
| Support Level | $8.64 | $6.93 |
| Resistance Level | $9.26 | $8.61 |
| Average True Range (ATR) | 0.21 | 0.54 |
| MACD | -0.03 | -0.13 |
| Stochastic Oscillator | 15.11 | 30.51 |
Price Performance
Historical ComparisonAbout FBRT Franklin BSP Realty Trust Inc.
Franklin BSP Realty Trust Inc is a private real estate investment trust that originates, acquires, and manages a diversified portfolio of commercial real estate debt, and first mortgage loans. secured by properties located in the United States. The Company's operations are organized into two business units: (i) Commercial Real Estate Financing, and (ii) Agency Business. Its four reporting segments are as follows: The real estate debt business, The Agency Business, The commercial real estate conduit business, and The real estate owned business.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.